Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity
D. Raffa et al., Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity, PHARMAZIE, 54(4), 1999, pp. 251-254
A novel series of 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)
amino] substituted 4(3H)-quinazolinone derivatives was synthesized. The com
pounds were tested for their antineoplastic activity in vitro against Raji
(human Burkitt limphoma), K-562 (human chronic myelogeneous leukemia) and U
937 (human histiocytic limphoma) cell lines. The most active quinazolinones
showed IC50 values in the range 16-30 mu M.